Starpharma releases positive DEP® phase 2 interim results in prostate cancer

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of

News story posted on 2021-11-26T07:41:00.0000000Z

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published.